You are here
- Home
- Therapy Areas
- Gastrointestinal
A randomized, double-blind, placebo controlled, study to evaluate the efficacy and safety of esomeprazole once daily for the treatment of gastroesophageal reflux disease (GERD) in neonatal patients, including premature and up to 1 month corrected age
- Disease
- acid reflux
- Drug Name
- Nexium
- Generic Name
- esomeprazole
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIa
- Start Date
- Oct 4, 2006
- Study Name
- D9614C00004
- Study Id
- D9614C00004
- ClinicalTrials.gov ID
- NCT00427635
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
